Long-term nitric oxide inhibition and chronotropic responses in rat isolated right atria

Hypertension

Volumn 34, Issue 4 II, 1999, Pages 802-807

  Riado, Sonia R ^a   Zanesco, Angelina ^b   Barker, Louis Allen ^c   De Luca, Iara M S ^a   Antunes, Edson ^a   De Nucci, Gilberto ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Adrenergic receptor agonists; Blood pressure; Nitric oxide; Receptors, adrenergic, beta; Receptors, muscarinic

Indexed keywords

CARBACHOL; ISOPRENALINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NORADRENALIN; PILOCARPINE;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHRONOTROPISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; HEART RIGHT ATRIUM; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032759169     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.34.4.802     Document Type: Article

References (30)

1. Peterson GL, Herron GS, Yamaki M, Fulllerton DS, Schimerlik MI. Purification of the muscarinic acetylcholine receptor from porcine atria. Proc Natl Acad Sci U S A. 1984;81:4993-4997.
2. Lands AM, Arnold A, McAuliff JP, Luduena FR, Brown TB. Differentiation of receptor systems activated by sympathomimetic amines. Nature (Lond). 1967;214:597-598.
3. O'Donnell SR, Wanstall JC. Response to the beta-2-selective agonist procaterol of vascular and atrial preparations with different functional beta-adrenoceptor populations. Br J Pharmacol. 1985;84:227-235.
4. Kauman AJ. The beta 1-adrenoceptor antagonist CGP 20712 A unmasks beta 2-adrenoceptors activated by (-)-adrenaline in rat sinoatrial node. Naunyn-Schmiedebergs Arch Pharmacol. 1986;332:406-409.
5. 3 receptors and rat atrial receptors mediating tachycardia. Br J Pharmacol. 1999;126:1018-1024.
6. 2-adrenoceptor binding and functional response in right atria and left atria of rat heart. Naunyn-Schmiedebergs Arch Pharmacol. 1985;330:199-202.
7. Bredt DS, Snyder SH. Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem. 1994;63:175-195.
8. Ribeiro MO, Antunes E, De Nucci G, Lovisolo SM, Zatz R. Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension. 1992;20:298-303.
9. Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest. 1992;90:278-281.
10. Moreno H Jr, Metze K, Bento AC, Antunes E, Zatz R, De Nucci G. Chronic nitric oxide inhibition as a model of hypertensive heart muscle disease. Basic Res Cardiovasc. 1996;91:248-255.
11. Pollock DM, Polakowski JS, Divish, BJ, Opgenorth TJ. Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition. Hypertension. 1993;21:660-666.
12. Moreno H Jr, Nathan LP, Costa SKP, Metze K, Antunes E, Zatz R, De Nucci G. Enalapril does not prevent the myocardial ischemia caused by the chronic inhibition of nitric oxide synthesis. Eur J Pharmacol. 1995; 287:93-96.
13. Cunha RS, Cabral AM, Vasquez EC. Evidence that the autonomic nervous system plays a major role in the L-NAME-induced hypertension in conscious rats. Am J Hypertens. 1993;6:806-809.
14. ω̄-nitro-L-arginine methyl ester. Hypertension. 1997;30: 64-70.
15. Zatz R. A low cost tail-cuff method for the stimulation of mean arterial pressure in conscious rats. Lab Anim Sci. 1990;40:198-201.
16. Hughes IE, Smith JA. The stability of noradrenaline in physiological salt solutions. J Pharm Pharmacol. 1978;30:124-126.
17. Van Rossum JM. Cumulative dose-response curves. II: technique for the making of dose-response curves in isolated organs and the evaluation of the drug parameters. Arch Intern Pharmacodyn Ther. 1963; 143:229-330.
18. Aherne W. Quantitative methods in histology. J Med Lab Technol. 1970; 27:160-170.
19. Shapoval LN, Sagach VF, Pobegailo LS. Nitric oxide influences ventrolateral medullary mechanisms of vasomotor control in the cat. Neurosci Lett. 1991;132:47-50.
20. Tagawa T, Imaizumi T, Harada S, Endo T, Shiramoto M, Hirooka Y, Takeshita A. Nitric oxide influences neuronal activity in the nucleus tractus solitarius of rat brainstem slices. Circ Res. 1994;75:70-76.
21. G-nitro-L-arginine-methyl-ester-induced hypertension: modulation by the renin-angiotensin system. J Hypertens. 1998;16:63-76.
22. Brodde O-E. Cardiac beta-adrenergic receptors. ISI Atlas Sci Pharmacol. 1987;1:107-112.
23. Lefkowitz R, Caron MG. Adrenergic receptors: models for the study of receptors coupled to guanine nucleotide regulatory proteins. J Biol Chem. 1988;263:4993-4996.
24. Kenakin T. Drugs and receptors: an overview of the current state of knowledge. Drugs. 1990;40:666-687.
25. Kennedy RH, Hicks KK, Brian JE Jr, Seifen E. Nitric oxide has no chronotropic effect in right atria isolated from rat heart. Eur J Pharmacol. 1994;255:149-156.
26. Weyrich AS, Ma XL, Buerke M, Murohara T, Armstead VE, Lefer AM, Nicolas JN, Thomas AP, Lefer DJ, Vinten-Johansen V. Physiological concentration of nitric oxide do not elicit an acute negative inotropic effect in unstimulated cardiac muscle. Circ Res. 1994;75:692-700.
27. G-nitro-L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ Res. 1993;72: 387-395.
28. Han X, Kubota I, Feron O, Opel DJ, Arstall MA, Zhao YY, Huang P, Fishamn MC, Michel T, Kelly RA. Muscarinic cholinergic regulation of cardiac myocytes ICa-L is absent in mice with targeted disruption of endothelial nitric oxide synthase. Proc Natl Acad Sci U S A. 1998;26: 6510-6515.
29. Kenakin T. Efficacy. In: Pharmacological Analysis of Drug-Receptor Interaction. New York, NY: Raven Press; 1993:249-278.
30. Vandecasteele G, Eschenhagen T, Scholz H, Stein B, Verde I, Fishmeister R. Muscarinic and beta-adrenergic regulation of heart rate, force of contraction and calcium current is preserved on mice lacking endothelial nitric oxide synthase. Nat Med. 1999;5:331-334.